Effects of Complementary Feeding on Infant Growth and Gut Health (MINT)

January 9, 2023 updated by: University of Colorado, Denver

This study plans to learn more about how consuming different foods during the time of early complementary feeding (~5 to 12 months) affects growth and the development of bacteria living inside your baby's gut. The results from this study will potentially help to support future recommendations and dietary guidance for infant feeding practices.

The three primary aims include:

Aim 1. Identify the impact of dietary patterns with different protein-rich foods on infant growth.

Aim 2. Identify the impact of dietary patterns with different protein-rich foods on infant gut microbiota development.

Aim 3. Identify gut microbial taxa and genes that affect infant growth.

Study Overview

Detailed Description

Some details are intentionally left to out to preserve the scientific integrity of the study, and they will be included in the record after the study is completed.

Study Type

Interventional

Enrollment (Anticipated)

300

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Colorado
      • Aurora, Colorado, United States, 80045
        • Recruiting
        • University of Colorado Anschutz Medical Campus

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

4 months to 4 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Full term;
  • Generally healthy without conditions that would affect protein metabolism or growth
  • No previous complementary food exposure
  • Vaginal delivery
  • No prior exposure of antibiotics during delivery or after birth
  • Able to consume study foods
  • Single birth.

Exclusion Criteria:

  • Pre-term infants.
  • Having conditions that would affect normal growth
  • Had complementary foods prior to the start of the study
  • Not willing to consume the complementary foods provided
  • Antibiotics exposure during delivery or from birth to 5 months of life
  • Multiple births

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Study Provided Diet - Meat
A group of complementary foods provided to participants by researchers.
Commercially available baby foods
Experimental: Study Provided Diet - Plant
A group of complementary foods provided to participants by researchers.
Commercially available baby foods
Experimental: Study Provided Diet - Dairy
A group of complementary foods provided to participants by researchers.
Commercially available baby foods
Placebo Comparator: Traditional Diet
No study foods provided to participants by researchers. Participants will eat a typical diet provided by caregivers.
Caregiver will provide participant with usual foods from the home

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Weight
Time Frame: Over 6 months
Measured in kg
Over 6 months
Length
Time Frame: Over 6 months
Measured in cm
Over 6 months
Head Circumference
Time Frame: Over 6 months
Measured in cm
Over 6 months
Body composition
Time Frame: Over 6 months
Body fat mass, fat-free mass measured by stable isotopes
Over 6 months
Gut Microbiome
Time Frame: Over 6 months
Gut microbiota structure by 16S sequencing
Over 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total calories in breast milk
Time Frame: Over 6 months
Measured in kcal/100 mL
Over 6 months
Total carbohydrates in breast milk
Time Frame: Over 6 months
Measured in g/100 mL
Over 6 months
Total protein in breast milk
Time Frame: Over 6 months
Measured in g/100 mL
Over 6 months
Total fat in breast milk
Time Frame: Over 6 months
Measured in g/100 mL
Over 6 months
Serum IGF-1 (Insulin-like growth factor1/ somatomedin C)
Time Frame: Over 6 months
Measured in ng/mL
Over 6 months
Serum IGFBP-3 (Insulin-like growth factor-binding protein 3)
Time Frame: Over 6 months
Measured in ng/mL
Over 6 months
Serum c-reactive protein (CRP-hs)
Time Frame: Over 6 months
Measured in mg/L
Over 6 months
Plasma alpha 1-acid glycoprotein (AGP)
Time Frame: Over 6 months
Measured in mg/L
Over 6 months
Dietary intake
Time Frame: Over 6 months
3 day dietary recall with results generated by NDSR software
Over 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2021

Primary Completion (Anticipated)

August 1, 2024

Study Completion (Anticipated)

August 1, 2024

Study Registration Dates

First Submitted

August 12, 2021

First Submitted That Met QC Criteria

August 12, 2021

First Posted (Actual)

August 19, 2021

Study Record Updates

Last Update Posted (Estimate)

January 11, 2023

Last Update Submitted That Met QC Criteria

January 9, 2023

Last Verified

January 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 20-2232
  • 1R01DK126710-01 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Gut Microbiome

Clinical Trials on Baby Foods - Meat

3
Subscribe